• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量静脉注射免疫球蛋白治疗急性细胞排斥反应后BK病毒血症增加及进展为BK病毒肾病。

Increased BK viremia and progression to BK-virus nephropathy following high-dose intravenous immunoglobulin for acute cellular rejection.

作者信息

Boonyapredee Maytee, Knight Kendral, Little Dustin

机构信息

Nephrology, Adventist Health Partners, 333 Chestnut Street, Suite L06, Hinsdale, IL 60521.

Department of Internal Medicine, Walter Reed National Military Medical Center, 8901 Wisconsin Avenue, Bethesda, MD 20889.

出版信息

Mil Med. 2014 Jun;179(6):e699-702. doi: 10.7205/MILMED-D-13-00489.

DOI:10.7205/MILMED-D-13-00489
PMID:24902140
Abstract

BK virus nephropathy and cellular rejection are common causes of allograft dysfunction in renal transplant recipients. The two can be difficult to distinguish on allograft biopsy and can be present simultaneously. Management of the patient with coexistent BK infection and rejection is complicated by the conflicting ideals of decreasing immunosuppression to treat the former and increasing immunosuppression to treat the latter. The authors present the case of a 57-year-old renal transplant recipient who underwent allograft biopsy 8 weeks post-transplant for evaluation of increased serum creatinine in the setting of BK viremia (BKV). Biopsy revealed Banff classification 1b acute cellular rejection, with insufficient evidence to diagnose BK virus-associated nephropathy. The patient was administered intravenous immune globulin (IVIG), with no other changes in immunosuppressive therapy. Plasma and urine BK increased exponentially following IVIG administration, and allograft function further deteriorated. Repeat biopsy showed overt BK viral nephropathy, and BKV and creatinine decreased only after reduction in immunosuppression and initiation of leflunomide. Although case series have suggested a potential role for IVIG in the setting of BK infection, further study is needed to define the safety and efficacy of this approach.

摘要

BK病毒肾病和细胞性排斥反应是肾移植受者移植肾功能障碍的常见原因。这两者在移植肾活检时可能难以区分,且可能同时存在。对于同时存在BK感染和排斥反应的患者,治疗起来很复杂,因为治疗前者需要降低免疫抑制,而治疗后者则需要增加免疫抑制,这两种理念相互冲突。作者介绍了一名57岁肾移植受者的病例,该患者在移植后8周因BK病毒血症(BKV)导致血清肌酐升高而接受移植肾活检。活检显示为班夫分类1b级急性细胞性排斥反应,没有足够证据诊断BK病毒相关性肾病。患者接受了静脉注射免疫球蛋白(IVIG)治疗,免疫抑制治疗没有其他变化。静脉注射免疫球蛋白后,血浆和尿液中的BK病毒呈指数级增加,移植肾功能进一步恶化。再次活检显示明显的BK病毒性肾病,只有在降低免疫抑制并开始使用来氟米特后,BKV和肌酐才下降。虽然病例系列研究表明IVIG在BK感染情况下可能有潜在作用,但需要进一步研究来确定这种方法的安全性和有效性。

相似文献

1
Increased BK viremia and progression to BK-virus nephropathy following high-dose intravenous immunoglobulin for acute cellular rejection.大剂量静脉注射免疫球蛋白治疗急性细胞排斥反应后BK病毒血症增加及进展为BK病毒肾病。
Mil Med. 2014 Jun;179(6):e699-702. doi: 10.7205/MILMED-D-13-00489.
2
Successful renal retransplantation after graft loss from BK polyomavirus infection in a human immunodeficiency virus-positive patient.一名人类免疫缺陷病毒阳性患者因BK多瘤病毒感染导致移植肾失功后成功进行肾再次移植。
Transpl Infect Dis. 2016 Dec;18(6):946-949. doi: 10.1111/tid.12615. Epub 2016 Nov 10.
3
Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy.在未进行抗病毒治疗的情况下,通过降低免疫抑制成功治疗BK病毒血症。
Transplantation. 2008 Mar 27;85(6):850-4. doi: 10.1097/TP.0b013e318166cba8.
4
Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.静脉注射免疫球蛋白治疗肾移植受者持续性BK病毒血症和BK病毒肾病的疗效
Clin Transpl. 2014:109-16.
5
BIOPSY-PROVEN BK VIRUS NEPHROPATHY WITHOUT DETECTABLE BK VIREMIA IN A ONE-YEAR POST-KIDNEY TRANSPLANT RECIPIENT.肾移植受者术后一年活检证实的BK病毒肾病,未检测到BK病毒血症
Southeast Asian J Trop Med Public Health. 2015 Jul;46(4):657-61.
6
Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.肾移植受者中BK多瘤病毒复制及肾病的前瞻性研究。
N Engl J Med. 2002 Aug 15;347(7):488-96. doi: 10.1056/NEJMoa020439.
7
Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.静脉注射免疫球蛋白治疗肾移植受者持续性BK病毒血症和BK病毒肾病的疗效
Transplant Proc. 2015 Mar;47(2):394-8. doi: 10.1016/j.transproceed.2015.01.012.
8
BK virus nephropathy: clinical experience in a university hospital in Japan.BK 病毒肾病:日本一所大学医院的临床经验。
Int J Urol. 2009 Dec;16(12):924-8. doi: 10.1111/j.1442-2042.2009.02400.x.
9
Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy.肾移植受者 BK 病毒肾病患者静脉注射免疫球蛋白后发生严重抗体介导的排斥反应。
Transpl Immunol. 2013 Jun;28(4):145-7. doi: 10.1016/j.trim.2013.05.004. Epub 2013 May 15.
10
BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.BK病毒血症监测与同期胰肾联合移植受者的预后
Clin Transplant. 2017 Aug;31(8). doi: 10.1111/ctr.13010. Epub 2017 Jun 12.

引用本文的文献

1
Neutralizing Antibodies Targeting BK Polyomavirus: Clinical Importance and Therapeutic Potential for Kidney Transplant Recipients.靶向 BK 多瘤病毒的中和抗体:肾移植受者的临床重要性和治疗潜力。
J Am Soc Nephrol. 2024 Oct 1;35(10):1425-1433. doi: 10.1681/ASN.0000000000000457. Epub 2024 Jul 9.
2
BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection.器官移植患者自体肾中的BK肾病:BK感染的临床谱
World J Transplant. 2016 Sep 24;6(3):472-504. doi: 10.5500/wjt.v6.i3.472.